Viewing Study NCT04910568


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2025-12-24 @ 5:38 PM
Study NCT ID: NCT04910568
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2021-05-27
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module